NX Development - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsNX Development

NX Development

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

No data

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Gleolan	Aminolevulinic acid	2017-06-06	2028-2040	Actinic keratosis

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

Aminolevulinic acid

,

,

head and neck neoplasms

,

skull base neoplasms

,

brain neoplasms

,

,

ovarian neoplasms

,

pituitary neoplasms

hematologic neoplasms

,

biphenotypic leukemia acute

,

b-cell leukemia

,

precursor cell lymphoblastic leukemia-lymphoma

,

stomach neoplasms

,

,

muscle spasticity

,

precursor t-cell lymphoblastic leukemia-lymphoma

,

precursor b-cell lymphoblastic leukemia-lymphoma

,

,

,

b-cell lymphoma

,

,

ovarian neoplasms

,

b-cell lymphoma marginal zone

,

fallopian tube neoplasms

,

multiple myeloma

,

prostatic neoplasms

,

pancreatic neoplasms

,

burkitt lymphoma

,

triple negative breast neoplasms

,

esophageal neoplasms

,

squamous cell carcinoma of head and neck

,

reactive arthritis

,

lymphoproliferative disorders

,

lymphatic diseases

,

intestinal neoplasms

,

colonic neoplasms

,

rectal neoplasms

,

,

,

,

neuroendocrine carcinoma

,

papillary thyroid cancer

,

,

primary myelofibrosis

,

hairy cell leukemia

,

abdominal hernia

,

,

myelodysplastic syndromes

,

breast neoplasms

,

urinary bladder neoplasms

,

uterine neoplasms

,

waldenstrom macroglobulinemia

,

choroidal effusions

,

myeloid leukemia

,

knee osteoarthritis

,

residual neoplasm

,

,

interstitial cystitis

,

neoadjuvant therapy

,

ovarian epithelial carcinoma

,

mantle-cell lymphoma

,

female genital neoplasms

,

,

non-hodgkin lymphoma

,

,

non-small-cell lung carcinoma

,

b-cell chronic lymphocytic leukemia

,

myeloid leukemia acute

,

,

colorectal neoplasms

,

large b-cell lymphoma diffuse

,

follicular lymphoma

,

,

,

musculoskeletal diseases

,

ankylosing spondylitis

,

small cell lung carcinoma

,

neoplasm metastasis

,

multiple sclerosis

,

relapsing-remitting multiple sclerosis

,

inflammatory bowel diseases

,

macular degeneration

,

wet macular degeneration

,

,

lymphoid leukemia

,

,

juvenile arthritis

,

,

papulosquamous skin diseases

,

,

communicable diseases

,

bacterial infections

,

methicillin-resistant staphylococcus aureus

,

staphylococcal skin infections

,

infectious skin diseases

,

bacterial skin diseases

,

,

disease progression

,

,

parkinson disease

,

bronchopulmonary dysplasia

,

respiratory syncytial viruses

,

,

,

pyoderma gangrenosum

,

spondylarthropathies

,

spondylarthritis

,

spinal diseases

,

,

intermediate uveitis

,

posterior uveitis

,

precocious puberty

,

migraine disorders

,

retinal diseases

,

retinal degeneration

,

,

choroidal neovascularization

,

hepatocellular carcinoma

,

liver neoplasms

,

thyroid diseases

,

,

rheumatoid arthritis

,

,

,

ulcerative colitis

,

psoriatic arthritis

,

,

chronic hepatitis c

,

hidradenitis suppurativa

,

axial spondyloarthritis

,

cardiovascular diseases

,

connective tissue diseases

,

,

,

,

drug monitoring

,

coronary artery disease

,

myocardial ischemia

,

,

atherosclerosis

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use